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Purpose: To develop an immobilisation device for prone positioning for breast irradiation. The basic requirements 
for the device are: rapid and accurate patient (re)positioning, compatibility with modern imaging devices and easy 
to handle by the treating technologists.
Material and methods: We used the anthropometric data from Dreyfuss to define the basic characteristics of the 
system in order to match the 2.5-97.5 percentile of the population for all support elements (arm, head, abdomen 
and legs). The “open” space corresponding to the region of interest to be treated (thorax/breast) was enlarged to 
allow more degrees of freedom for beam angulations (inclusive non-coplanar beam orientations). The size of the 
immobilisation device and the patient contour according to the anthropometric data were taken into account so 
that the whole set-up matches the bore size of the computed tomography scanner (82 cm). The support for the 




Conclusion: The device will now be used prospectively in a trial to compare the prone versus supine positioning. 
We will define and report the impact of prone versus supine positioning on vector displacement of boost area, 
compare the dosimetry using our Pinnacle® treatment planning both with 3D conformal radiotherapy as well as 
IMRT, both with or without considering respiratory movement (Protocol B70720084765): endpoints are 
homogeneity index, conformality index, mean heart diameter within tangential fields and V30, V5-V15-V20 lung.
